Contents of this document
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | 102,038 Millions of yen (YoY +53.9%) |
| Operating profit | 5,637 Millions of yen (YoY +210.3%) |
| Ordinary income | 5,223 Millions of yen (YoY +225.3%) |
| Net income | 5,759 Millions of yen (YoY +500.8%) |
| Operating profit margin | 5.5 % |
| Results for the three months of the current quarter | Quarterly trends in net sales and operating profit by location were disclosed in charts. |
| Full-year earnings forecast | Net Sales 198,700 Millions of yen / Operating profit 8,000 Millions of yen / Ordinary income 7,300 Millions of yen / Profit for the period 5,600 Millions of yen |
| Segment results | Resin-Processed Products Business Net Sales 88,977 Millions of yen (YoY +65.0%) / Operating profit 5,171 Millions of yen (YoY +149.0%) / Chemicals Business Net Sales 13,061 Millions of yen (YoY +5.5%) / Operating profit 1,385 Millions of yen (YoY +116.5%) |
| Unit price and quantity metrics | Increases in sales volumes and revisions to selling prices are mentioned, but the figures for volume and unit price are not disclosed. |
| Assumptions Underlying the Business Outlook | Foreign exchange US dollar ¥150.0 / Chinese yuan ¥22.1 |
| New initiatives | Consolidation of Moriroku ReNova in connection with the M&A |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased in the Resin Processing Products business due to the consolidation effects of Moriroku ReNova following the M&A and increased production in North America, and in the Chemicals business due to higher sales volumes resulting from the impact of the situation in the Middle East. In addition to higher revenue, operating profit benefited from increased mold transactions, an improved model mix and revisions to selling prices in the Chemicals business. In addition to the increase in operating profit, net income included a gain on negative goodwill arising from the acquisition.